A Randomized, Double-blind, Placebo-controlled, Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied Four Times Daily in Subjects Experiencing Acute Delayed Onset Muscle Soreness (DOMS) of the Lower Limbs
Phase of Trial: Phase III
Latest Information Update: 13 Apr 2016
At a glance
- Drugs Diclofenac (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Novartis
- 29 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Dec 2014 Planned number of patients changed from 86 to 102 as reported by ClinicalTrials.gov record.
- 27 Oct 2014 New trial record